{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:58:04Z","timestamp":1784289484716,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.yebeh.2024.109951","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:46:50Z","timestamp":1722991610000},"page":"109951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical characteristics and treatment approach of established New-Onset status epilepticus (eNOSE): A Real-World multicenter experience"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3575-2942","authenticated-orcid":false,"given":"Fedele","family":"Dono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1828-5345","authenticated-orcid":false,"given":"Giacomo","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Rodorigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Rollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-3141","authenticated-orcid":false,"given":"Marina","family":"Romozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Corniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Liviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Dasara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Capriati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Quintieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0529-7686","authenticated-orcid":false,"given":"Serenella","family":"Servidei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-799X","authenticated-orcid":false,"given":"Giacomo","family":"Della Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0326-5509","authenticated-orcid":false,"given":"Paolo","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-2574","authenticated-orcid":false,"given":"Stefano L.","family":"Sensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9371-8035","authenticated-orcid":false,"given":"Catello","family":"Vollono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.109951_b0005","doi-asserted-by":"crossref","unstructured":"Rui-Juan Lv, Qun Wang, Tao Cui, Fei Zhu, Xiao-Qiu Shao. Status epilepticus-related etiology, incidence and mortality: A meta-analysis, Epilepsy Research, Volume 136, 2017, Pages 12-17, ISSN 0920-1211, Doi: 10.1016\/j.eplepsyres.2017.07.006.","DOI":"10.1016\/j.eplepsyres.2017.07.006"},{"key":"10.1016\/j.yebeh.2024.109951_b0010","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus \u2013 Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109951_b0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","article-title":"Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus\u2013approach to clinical application","volume":"49","author":"Leitinger","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"7","key":"10.1016\/j.yebeh.2024.109951_b0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2024.109951_b0025","unstructured":"Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, Rogers A, Barsan W, Cloyd J, Lowenstein D, Bleck TP, Conwit R, Meinzer C, Cock H, Fountain NB, Underwood E, Connor JT, Silbergleit R; Neurological Emergencies Treatment Trials; Pediatric Emergency Care Applied Research Network investigators. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020 Apr 11;395(10231):1217-1224. doi: 10.1016\/S0140-6736(20)30611-5. Epub 2020 Mar 20. Erratum in: Lancet. 2023 May 6;401(10387):1498. PMID: 32203691; PMCID: PMC7241415."},{"key":"10.1016\/j.yebeh.2024.109951_b0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/epi.12058","article-title":"Lacosamide as a new treatment option in status epilepticus","volume":"54","author":"H\u00f6fler","year":"2013","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2024.109951_b0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/01.WNL.0000042783.86439.27","article-title":"The use of topiramate in refractory status epilepticus","volume":"60","author":"Towne","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2024.109951_b0045","doi-asserted-by":"crossref","unstructured":"Francesco Brigo, Simona Lattanzi, Alexandra Rohracher, Emilio Russo, Stefano Meletti, Elisabetta Grillo, Eugen Trinka. Perampanel in the treatment of status epilepticus: A systematic review of the literature, Epilepsy & Behavior, Volume 86, 2018, Pages 179-186, ISSN 1525-5050, Doi: 10.1016\/j.yebeh.2018.07.004.","DOI":"10.1016\/j.yebeh.2018.07.004"},{"key":"10.1016\/j.yebeh.2024.109951_b0050","doi-asserted-by":"crossref","unstructured":"Niccol\u00f2 Orlandi, Emanuele Bartolini, Daniela Audenino, Mario Coletti Moja, Lidia Urso, Giuseppe d'Orsi, Giada Pauletto, Annacarmen Nilo, Lucia Zinno, Roberto Cappellani, Leila Zummo, Antonello Giordano, Filippo Dainese, Peiman Nazerian, Francesca Pescini, Simone Beretta, Fedele Dono, Luigi del Gaudio, Monica Ferlisi, Daniela Marino, Marta Piccioli, Rosaria Renna, Eleonora Rosati, Adriana Rum, Gionata Strigaro, Giada Giovannini, Stefano Meletti, Salvatore M. Cavalli, Margherita Contento, Salvatore Cottone, Maria Teresa Di Claudio, Irene Florindo, Martina Guadagni, Lorenzo Kiferle, Delia Lazzaretti, Matilde Lazzari, Daniele Lo Coco, Silvia Pradella, Klaudio Rikani, Davide Rodorigo, Annarita Sabetta, Luigi Sicurella, Valentina Tontini, Giulia Turchi, Anna E. Vaudano, Tiziano Zanoni. Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy, Seizure, Volume 86, 2021, Pages 70-76, ISSN 1059-1311, Doi: 10.1016\/j.seizure.2021.01.014.","DOI":"10.1016\/j.seizure.2021.01.014"},{"issue":"6","key":"10.1016\/j.yebeh.2024.109951_b0055","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1212\/WNL.0000000000012292","article-title":"Safety and efficacy of coma induction following first-line treatment in status epilepticus: a 2-center study","volume":"97","author":"De Stefano","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2024.109951_b0060","doi-asserted-by":"crossref","unstructured":"M.P. Malter, R.D. Nass, T. Kaluschke, G.R. Fink, L. Burghaus, C. Dohmen. New onset status epilepticus in older patients: Clinical characteristics and outcome, Seizure, Volume 51, 2017, Pages 114-120, ISSN 1059-1311, Doi: 10.1016\/j.seizure.2017.08.006.","DOI":"10.1016\/j.seizure.2017.08.006"},{"key":"10.1016\/j.yebeh.2024.109951_b0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fneur.2023.1101370","article-title":"Specific profiles of new-onset (NOSE) vs non-inaugural (NISE) status epilepticus: from diagnosis to one-year outcome","volume":"14","author":"Benaiteau","year":"2023","journal-title":"Front Neurol"},{"issue":"7","key":"10.1016\/j.yebeh.2024.109951_b0070","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/CCM.0000000000003776","article-title":"The clinical spectrum of new-onset status epilepticus","volume":"47","author":"Chakraborty","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.yebeh.2024.109951_b0075","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","article-title":"Status epilepticus severity score (STESS)","volume":"255","author":"Rossetti","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2024.109951_b0080","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1468-1331.2006.01397.x","article-title":"EFNS guideline on the management of status epilepticus","volume":"13","author":"Meierkord","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2024.109951_b0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.yebeh.2015.04.038","article-title":"Comparison of the effectiveness of four antiepileptic drugs in the treatment of status epilepticus according to four different efficacy criteria","volume":"49","author":"Redecker","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2024.109951_b0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2013.12.007","article-title":"The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies","volume":"23","author":"Yasiry","year":"2014","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2024.109951_b0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1751-0473-3-17","article-title":"Purposeful selection of variables in logistic regression","volume":"16","author":"Bursac","year":"2008","journal-title":"Source Code Biol Med"},{"issue":"1","key":"10.1016\/j.yebeh.2024.109951_b0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the american epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2024.109951_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109093","article-title":"Treatment of benzodiazepine-refractory status epilepticus: A retrospective, cohort study","volume":"140","author":"Rollo","year":"2023","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2024.109951_b0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/ene.13560","article-title":"A critical appraisal of randomized controlled trials on intravenous phenytoin in convulsive status epilepticus","volume":"25","author":"Brigo","year":"2018","journal-title":"Eur J Neurol"},{"issue":"12","key":"10.1016\/j.yebeh.2024.109951_b0115","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans affairs status epilepticus cooperative study group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2024.109951_b0120","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.eplepsyres.2005.07.020","article-title":"Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus","volume":"68","author":"Treiman","year":"2006","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.yebeh.2024.109951_b0125","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.yebeh.2024.109951_b0130","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2011.03056.x","article-title":"Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam","volume":"52","author":"Alvarez","year":"2011","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.yebeh.2024.109951_b0135","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1474-4422(08)70141-8","article-title":"Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study","volume":"7","author":"Chin","year":"2008","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2024.109951_b0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.annemergmed.2022.04.020","article-title":"Treatment of toxin-related status epilepticus with levetiracetam, fosphenytoin, or valproate in patients enrolled in the established status epilepticus treatment trial","volume":"80","author":"Coralic","year":"2022","journal-title":"Ann Emerg Med"},{"issue":"14","key":"10.1016\/j.yebeh.2024.109951_b0145","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.2147\/IJGM.S295855","article-title":"Epidemiology and outcomes of status epilepticus","volume":"28","author":"Ascoli","year":"2021","journal-title":"Int J Gen Med"},{"issue":"3","key":"10.1016\/j.yebeh.2024.109951_b0150","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/epi.12064","article-title":"Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study","volume":"54","author":"Sutter","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109951_b0155","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.yebeh.2015.04.010","article-title":"Preliminary results of the global audit of treatment of refractory status epilepticus","volume":"49","author":"Ferlisi","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2024.109951_b0160","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jamaneurol.2013.578","article-title":"Predictors of outcome in refractory status epilepticus","volume":"70","author":"Hocker","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2024.109951_b0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1528-1167.2005.00409.x","article-title":"Mortality after a first episode of status epilepticus in the United States and Europe","volume":"46","author":"Logroscino","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109951_b0170","first-page":"131","article-title":"Comparison of clinical profile and outcome of de novo convulsive status epilepticus with those with a past history of epilepsy in the elderly populace","volume":"31","author":"Verma","year":"2022","journal-title":"Acta Neurol Taiwanica"},{"key":"10.1016\/j.yebeh.2024.109951_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106675","article-title":"Management of status epilepticus in adults. position paper of the Italian League against Epilepsy","volume":"102","author":"Minicucci","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.109951_b0180","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2024.109951_b0185","doi-asserted-by":"crossref","unstructured":"Sathe AG, Tillman H, Coles LD, Elm JJ, Silbergleit R, Chamberlain J, Kapur J, Cock HR, Fountain NB, Shinnar S, Lowenstein DH, Conwit RA, Bleck TP, Cloyd JC. Underdosing of Benzodiazepines in Patients With Status Epilepticus Enrolled in Established Status Epilepticus Treatment Trial. Acad Emerg Med. 2019 Aug;26(8):940-943. doi: 10.1111\/acem.13811. Epub 2019 Jul 18. PMID: 31161706; PMCID: PMC8366410.","DOI":"10.1111\/acem.13811"},{"issue":"4","key":"10.1016\/j.yebeh.2024.109951_b0190","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/epi.14022","article-title":"New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives","volume":"59","author":"Gaspard","year":"2018","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.yebeh.2024.109951_b0195","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/ene.13073","article-title":"A new clinical score for the prognosis of status epilepticus in adults","volume":"23","author":"Gonz\u00e1lez-Cuevas","year":"2016","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2024.109951_b0200","doi-asserted-by":"crossref","first-page":"1081757","DOI":"10.3389\/fepid.2023.1081757","article-title":"Mortality, and life expectancy in Epilepsy and Status epilepticus-current trends and future aspects","volume":"23","author":"Trinka","year":"2023","journal-title":"Front Epidemiol"},{"key":"10.1016\/j.yebeh.2024.109951_b0205","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clineuro.2015.09.010","article-title":"Status epilepticus severity score (STESS): A useful tool to predict outcome of status epilepticus","volume":"139","author":"Goyal","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"10.1016\/j.yebeh.2024.109951_b0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12028-014-0080-y","article-title":"Epidemiology-based mortality score in status epilepticus (EMSE)","volume":"22","author":"Leitinger","year":"2015","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.yebeh.2024.109951_b0030","doi-asserted-by":"crossref","unstructured":"Eugen Trinka. Phenobarbital in Status epilepticus \u2013 Rediscovery of an effective drug. Epilepsy Behav Volume 141, 2023, 109104, ISSN 1525-5050, Doi: 10.1016\/j.yebeh.2023.109104.","DOI":"10.1016\/j.yebeh.2023.109104"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024003329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024003329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T04:15:06Z","timestamp":1726373706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024003329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":42,"alternative-id":["S1525505024003329"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109951","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and treatment approach of established New-Onset status epilepticus (eNOSE): A Real-World multicenter experience","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109951"}}